Log in

LON:CREOCreo Medical Group Share Price, Forecast & News

GBX 145
+2.50 (+1.75 %)
(As of 05/26/2020 06:03 AM ET)
Today's Range
Now: GBX 145
50-Day Range
MA: GBX 129.28
52-Week Range
Now: GBX 145
Volume952 shs
Average Volume16,051 shs
Market Capitalization£228.40 million
P/E RatioN/A
Dividend YieldN/A
Creo Medical Limited develops and sells instruments for surgical endoscopy in the United Kingdom. The company is developing instruments for endoscopy through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. It offers Speedboat RS2 instrument for endoscopic submucosal dissection. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was founded in 2003 and is based in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices



Sales & Book Value

Annual Sales£7,699.00
Price / Sales29,666.71
Cash FlowGBX 32.47 per share
Book ValueGBX 33.40 per share



Market Cap£228.40 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CREO News and Ratings via Email

Sign-up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter.

Creo Medical Group (LON:CREO) Frequently Asked Questions

How has Creo Medical Group's stock been impacted by COVID-19 (Coronavirus)?

Creo Medical Group's stock was trading at GBX 143.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CREO stock has increased by 1.0% and is now trading at GBX 145. View which stocks have been most impacted by Coronavirus.

How were Creo Medical Group's earnings last quarter?

Creo Medical Group PLC (LON:CREO) announced its quarterly earnings data on Tuesday, March, 20th. The company reported ($5.00) EPS for the quarter. View Creo Medical Group's earnings history.

Has Creo Medical Group been receiving favorable news coverage?

Press coverage about CREO stock has been trending very negative this week, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Creo Medical Group earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutCreo Medical Group.

Who are some of Creo Medical Group's key competitors?

What other stocks do shareholders of Creo Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Creo Medical Group investors own include Mysquare (MYSQ) and IQE (IQE).

Who are Creo Medical Group's key executives?

Creo Medical Group's management team includes the following people:
  • Mr. Craig Jonathan Gulliford, CEO & Director (Age 48)
  • Prof. Christopher Paul Hancock, Founder, CTO & Director (Age 51)
  • Mr. Richard John Rees ACA, CFO, Company Sec. & Director (Age 42)
  • Mr. Phil Hales, Sales & Marketing Director

What is Creo Medical Group's stock symbol?

Creo Medical Group trades on the London Stock Exchange (LON) under the ticker symbol "CREO."

How do I buy shares of Creo Medical Group?

Shares of CREO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Creo Medical Group's stock price today?

One share of CREO stock can currently be purchased for approximately GBX 145.

How big of a company is Creo Medical Group?

Creo Medical Group has a market capitalization of £228.40 million and generates £7,699.00 in revenue each year. Creo Medical Group employs 50 workers across the globe.

What is Creo Medical Group's official website?

The official website for Creo Medical Group is creomedical.com.

How can I contact Creo Medical Group?

The company can be reached via phone at +44-1291-606005.

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.